Mitchell Blutt, MD

Consonance Capital, CEO and Founder

​Mitchell Blutt, MD is the CEO of Consonance Capital, a health care focused investment firm. He is the former Executive Partner of J.P. Morgan Partners (JPMP). He is a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medicine.

 

Dr. Blutt completed his BA and MD degrees at the University of Pennsylvania and he received his MBA from the Wharton School of the University of Pennsylvania through the Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He completed his residency in Internal Medicine at New York-Presbyterian/Weill Cornell Medical Center.

 

Dr. Blutt has served on numerous boards of directors, including Cardinal Health, Cooper Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, Thermoscan and KEPRO. He also formerly served on the Board of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of the University of Pennsylvania, and the Board of The Brearley School. 

 

Dr. Blutt currently serves on numerous boards at the University of Pennsylvania including the Board of Advisors of the School of Arts and Sciences and the Board of Advisors of the Wharton School; he also serves as the Chairman of the External Advisory Board of CHIBE (Center for Health Incentives and Behavioral Economics), and is a member of the External Advisory Board of The Penn brainSTIM Center.  Dr. Blutt is a recipient of the Alumni Award of Merit, the University of Pennsylvania’s highest honor. Additionally, Dr. Blutt is a member of the Board of Fellows of Weill Cornell Medicine and  the Co-Chairman of its Special Committee on Equity, Diversity and Inclusion;  the Executive Committee of the Dean’s Council, an advisory board to the Dean; the New York Weill Cornell Council, an advisory board to the New York-Presbyterian/Weill Cornell Medical Center.  He's also a member of the External Board of Directors of CABM (Center for Advanced Biotechnology and Medicine), Rutgers University. In addition, Dr. Blutt serves on the Board of Directors of The Commonwealth Fund, a private foundation that supports independent research on health and social issues and makes grants to improve health care practice and policy. Dr. Blutt is also a member of the  Board of Bako, a premier national provider of specialty laboratory testing and other high quality pathology services, and PMC (Psychiatric Medical Care), the leading operator of inpatient and outpatient behavioral health programs in rural communities. Dr. Blutt was the Chairman of the Board of Directors of Consonance-HFW Acquisition Corp., a life sciences special purpose acquisition company (affiliated with Consonance Capital Management, the hedge fund management company of Consonance Capital).

 

Dr. Blutt founded Consonance Capital in 2005.

___media_images_news_2014_mitchell_blutt